Digkas, Evangelos http://orcid.org/0000-0003-0429-6200
Smith, Daniel Robert
Wennstig, Anna-Karin
Matikas, Alexios
Tegnelius, Eva
Valachis, Antonios
Funding for this research was provided by:
Uppsala University
Article History
Received: 30 June 2023
Accepted: 5 November 2023
First Online: 7 December 2023
Declarations
:
: Financial interests: AM has performed consultancy for Veracyte (no financial or other compensation) and Roche (no financial or other compensation). ET has received speaker honoraria from Roche. Non-financial interests: AM has served on advisory boards for Veracyte and Roche, while he has received research funding paid to institution by AstraZeneca and Novartis. Authors ED, DS, AKW, and AV declare they have no conflict of interests.
: The study was approved by the Ethical Review Board in Stockholm (EPN Stockholm) dnr 2013/1272-31/4, with supplements approved dnr 2020-06312.
: Considering the observational nature of this register-based study, informed consent was waived from the Ethical Review Board.